Your browser doesn't support javascript.
loading
Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II-III).
Shafran, S D; Shaw, D; Charafeddine, M; Agarwal, K; Foster, G R; Abunimeh, M; Pilot-Matias, T; Pothacamury, R K; Fu, B; Cohen, E; Cohen, D E; Gane, E.
Afiliação
  • Shafran SD; Division of Infectious Diseases, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada.
  • Shaw D; Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Charafeddine M; AbbVie Inc., North Chicago, IL, USA.
  • Agarwal K; Institute of Liver Studies, Kings College Hospital, London, UK.
  • Foster GR; Queen Mary University of London, Barts Health, London, UK.
  • Abunimeh M; AbbVie Inc., North Chicago, IL, USA.
  • Pilot-Matias T; AbbVie Inc., North Chicago, IL, USA.
  • Pothacamury RK; AbbVie Inc., North Chicago, IL, USA.
  • Fu B; AbbVie Inc., North Chicago, IL, USA.
  • Cohen E; AbbVie Inc., North Chicago, IL, USA.
  • Cohen DE; AbbVie Inc., North Chicago, IL, USA.
  • Gane E; Liver Unit, Auckland City Hospital, Auckland, New Zealand.
J Viral Hepat ; 25(2): 118-125, 2018 02.
Article em En | MEDLINE | ID: mdl-28833938
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C / Resposta Viral Sustentada / Cirrose Hepática Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C / Resposta Viral Sustentada / Cirrose Hepática Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article